Effects of Murine and Human Bone Marrow-Derived Mesenchymal Stem Cells on Cuprizone Induced Demyelination

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Nessler, Jasmin ^a   Bénardais, Karelle ^a,b   Gudi, Viktoria ^a   Hoffmann, Andrea ^a   Salinas Tejedor, Laura ^a,b   Janßen, Stefanie ^a,b   Prajeeth, Chittappen Kandiyil ^a   Baumgärtner, Wolfgang ^b,c   Kavelaars, Annemieke ^d,e   Heijnen, Cobi J ^d,e   van Velthoven, Cindy ^e   Hansmann, Florian ^c   Skripuletz, Thomas ^a   Stangel, Martin ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CUPRIZONE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN; CELL VIABILITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROGLIA; MOUSE; NONHUMAN; OLIGODENDROGLIA; REMYELINIZATION; SPINAL CORD;

ANIMALS; BONE MARROW CELLS; CELL COUNT; CELL TRACKING; CHEMOKINES; CORPUS CALLOSUM; CUPRIZONE; CYTOPROTECTION; DEMYELINATING DISEASES; FEEDING BEHAVIOR; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA4; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; OLIGODENDROGLIA; ORGANIC CHEMICALS; RNA, MESSENGER;

EID: 84880849959     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069795     Document Type: Article

References (51)

1. Howard BV, Abbott WG, Swinburn BA, (1991) Evaluation of metabolic effects of substitution of complex carbohydrates for saturated fat in individuals with obesity and NIDDM. Diab Care 14: 786-795.
2. Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, et al. (2010) Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 67: 1187-1194.
3. Nylander A, Hafler DA, (2012) Review series Multiple sclerosis. pp. 122.
4. Shahab-Osterloh S, Witte F, Hoffmann A, Winkel A, Laggies S, et al. (2010) Mesenchymal stem cell-dependent formation of heterotopic tendon-bone insertions (osteotendinous junctions). Stem Cells 28: 1590-1601.
5. van Velthoven CTJ, Kavelaars A, van Bel F, Heijnen CJ, (2009) Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes. Brain Res Rev 61: 1-13.
6. McMahon EJ, Suzuki K, Matsushima GK, (2002) Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. J Neuroimmunol 130: 32-45.
7. Bolanos aR, Sarkisian M, Yang Y, Hori a, Helmers SL, et al. (1998) Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurol 51: 41-48.
8. Pittenger MF, (1999) Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science 284: 143-147.
9. Prockop DJ, Gregory Ca, Spees JL, (2003) One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. PNAS 100: 11917-11923.
10. McFatter RM, Basic Principles in the Design and Evaluation of Experiments.
11. Compston A, Coles A, (2008) Multiple sclerosis. Lancet 372: 1502-1517.
12. Prineas JW, Parratt JDE, (2012) Oligodendrocytes and the early multiple sclerosis lesion. Ann Neurol 72: 18-31.
13. Anderson JM, Hampton DW, Patani R, Pryce G, Crowther Ra, et al. (2008) Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. Brain 131: 1736-1748.
14. van Velthoven CTJ, Kavelaars A, van Bel F, Heijnen CJ, (2010) Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 30: 9603-9611.
15. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, et al. (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-1761.
16. Buhr RJ, Abbott UK, Abplanalp H, Tyler WS, (1991) Effects of the sex-linked dwarf gene (dw) on the expression of the muscular dystrophy gene (am) in chicken. J Hered 82: 465-470.
17. van Velthoven CTJ, Kavelaars A, van Bel F, Heijnen CJ, (2011) Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain. Brain Behav Immun 25: 1342-1348.
18. Danielyan L, Schäfer R, von Ameln-Mayerhofer A, Bernhard F, Verleysdonk S, et al. (2011) Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuv Res 14: 3-16.
19. Gordon D, Pavlovska G, Uney JB, Wraith DC, Scolding NJ, (2010) Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis. J Neuropathol Experime Neurol 69: 1087-1095.
20. Abbott KA, McFarland IJ, (1991) Trichostrongylus axei infection as a cause of deaths and loss of weight in sheep. Aust Vet J 68: 368-369.
21. Abbott KC, Vukelja SJ, Smith CE, McAllister CK, Konkol KA, et al. (1991) Hemophagocytic syndrome: a cause of pancytopenia in human ehrlichiosis. Am J Hematol 38: 230-234.
22. Baker BW, Smith MP, Abbott GD, Beard ME, Spearing RL, et al. (1991) Aplastic anaemia in Christchurch Hospital 1979-89. N Z Med J 104: 468-470.
23. Abbott D, Lowrey A, (1991) Car tax: steering through taxation. Nurs Stand 6: 54-55.
24. Bakker DA, Ludwin SK, (1987) Blood-brain barrier permeability during Cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases. J Neurol Sci 78: 125-137.
25. Matsushima GK, Morell P, (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11: 107-116.
26. Skripuletz T, Gudi V, Hackstette D, Stangel M, (2011) De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol Histopathol 26: 1585-1597.
27. Kontorinis G, Scheper V, Wissel K, Stover T, Lenarz T, et al. (2012) In vitro modifications of the scala tympani environment and the cochlear implant array surface. Laryngoscope 122: 2057-2063.
28. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
29. Sung JH, Yang HM, Park JB, Choi GS, Joh JW, et al. (2008) Isolation and characterization of mouse mesenchymal stem cells. Transpl Proc 40: 2649-2654.
30. Myers RA, Zafaralla GC, Gray WR, Abbott J, Cruz LJ, et al. (1991) alpha-Conotoxins, small peptide probes of nicotinic acetylcholine receptors. Biochem 30: 9370-9377.
31. Abbott BD, Pratt RM, (1991) Retinoic acid alters epithelial differentiation during palatogenesis. J Craniofac Genet Dev Biol 11: 315-325.
32. Skripuletz T, Miller E, Grote L, Gudi V, Pul R, et al. (2011) Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system. Brain Behav Immun 25: 1592-1606.
33. Wright MR, Axelson JE, Abbott FS, Riggs KW, Van der Weyde MP, et al. (1991) Determination of ritodrine in biological fluids of the pregnant sheep by fused-silica capillary gas chromatography using electron-capture detection. J Chromatogr 565: 225-236.
34. Gudi V, Moharregh-Khiabani D, Skripuletz T, Koutsoudaki PN, Kotsiari A, et al. (2009) Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res 1283: 127-138.
35. Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, et al. (2008) Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172: 1053-1061.
36. Gudi V, Skuljec J, Yildiz O, Frichert K, Skripuletz T, et al. (2011) Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming. PLoS One 6: e22623.
37. Skripuletz T, Hackstette D, Bauer K, Gudi V, Pul R, et al. (2013) Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain 136: 147-167.
38. Benardais K, Kotsiari A, Skuljec J, Koutsoudaki PN, Gudi V, et al. (2013) Cuprizone [Bis(Cyclohexylidenehydrazide)] is Selectively Toxic for Mature Oligodendrocytes. Neurotox Res.
39. Blakemore WF, Irvine Ka, (2008) Endogenous or exogenous oligodendrocytes for remyelination. J Neurol Sci 265: 43-46.
40. Maijenburg MW, van der Schoot CE, Voermans C, (2012) Mesenchymal stromal cell migration: possibilities to improve cellular therapy. Stem Cells Dev 21: 19-29.
41. Vogel S, Trapp T, Borger V, Peters C, Lakbir D, et al. (2010) Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells. Cell Mol Life Sci 67: 295-303.
42. Xu F, Shi J, Yu B, Ni W, Wu X, et al. (2010) Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro. Oncol Rep 23: 1561-1567.
43. Jurevics H, Largent C, Hostettler J, Sammond DW, Matsushima GK, et al. (2002) Alterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination. J Neurochem 82: 126-136.
44. D'Costa DF, Abbott RJ, Pye IF, Millac PA, (1991) The apomorphine test in parkinsonian syndromes. J Neurol Neurosurg Psychiatry 54: 870-872.
45. Ong EL, Bilton D, Abbott J, Webb AK, McCartney RA, et al. (1991) Influenza vaccination in adults with cystic fibrosis. BMJ 303: 557.
46. Kang ES, Ha KY, Kim YH, (2012) Fate of transplanted bone marrow derived mesenchymal stem cells following spinal cord injury in rats by transplantation routes. J Korean Med Sci 27: 586-593.
47. Velthoven CTJv, Kavalaars A, Bel Fv, Heijnen CJ, (2010) Nasal Administration of Stem Cells: A Promising Novel Route to. Ped Res 68: 419-422.
48. Mishima Y, Lotz M, (2008) Chemotaxis of human articular chondrocytes and mesenchymal stem cells. J Orthop Res 26: 1407-1412.
49. Fiedler J, Leucht F, Waltenberger J, Dehio C, Brenner RE, (2005) VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334: 561-568.
50. Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, et al. (2009) Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem cells 27: 2624-2635.
51. Cowen LA, Harold MR, Chen CM, Abbott RE, Schachter D, (1991) Immunoglobulin and renal abnormalities in Dahl genetically hypertensive rat. Am J Physiol 261: H1895-1902.